🔴 Indaptus Therapeutics is trading 5.8% down today on profit-taking after recent rebound

Indaptus Therapeutics is trading 5.8% down at $1.72 on profit-taking following a sharp multi-day rebound.

• The stock's decline follows a period of significant strength, including a 5% gain on July 29 and a 6.6% jump during pre-market trading.
• With no fresh company-specific news or filings today, the move appears driven by short-term volatility and profit-taking in the thinly traded biotech name.
• The pullback occurs despite a modest rebound across broader U.S. equity markets.